VHL and renal cell carcinoma: Evidence of biallelic loss of VHL function by compound heterozygosity and promoter methylation, and the discovery of hypoxia-inducible factor-1 (HIF-1) and its link to the VHL pathway, laid the foundation to target angiogenesis in RCC [12].